Top Markets
#1 MowCat MowCat +806.52%
#2 龙虾 (Lobster) 龙虾 (Lobster) +86.27%
#3 SODAX SODAX +49.21%
#4 Cortex Cortex +27.15%
#5 Magma Finance Magma Finance +20.46%
#6 Pons Pons +19.72%
#7 Akedo Akedo +18.11%
#8 OpenEden OpenEden +14.22%
#9 MANTRA MANTRA +12.93%
#10 APEX APEX +12.08%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Mezzion Pharma Co.,Ltd. Mezzion Pharma Co.,Ltd.

Mezzion Pharma Co.,Ltd.

140410
Rank in Stocks #7810
Mezzion Pharma Co., Ltd. operates as a pharmaceutical enterprise focused on the... Mezzion Pharma Co., Ltd. operates as a pharmaceutical enterprise focused on the discovery, production, and licensing of various medical treatments. The company's therapeutic offerings target conditions such as erectile dysfunction, benign prostatic hyperplasia, and Fontan disease. Established by Park, Dong-Hyun on September 25, 2002, its corporate base is located in Seoul, South Korea.
Share Price
$47.85
Market Cap
$1.45B
Change (1 day)
4.22%
Change (1 year)
63.29%
Country
KR
Trade Mezzion Pharma Co.,Ltd. (140410)

Category

Healthcare
P/E ratio for Mezzion Pharma Co.,Ltd. (140410)
P/E ratio as of 2026 TTM: 0
According to Mezzion Pharma Co.,Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Mezzion Pharma Co.,Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 24.32 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 31.46 -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.